Inhibitex (INHX -6.4%) had an interesting day. Shares fell as much as 16% in early trading,...


Inhibitex (INHX -6.4%) had an interesting day. Shares fell as much as 16% in early trading, apparently due to cautious comments from BofA's Rachel McMinn, who thinks there could be considerable downside if a safety check for the company's INX-189 hepatitis drug turns up any issues. However, shares pared the majority of their losses after other analysts came to Inhibitex's defense.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs